Cargando…
Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors
Background: Up to 40% of women with atypical endometrial hyperplasia (AEH) can reveal endometrial cancer (EC) at hysterectomy. The pre-operative endometrial sampling method (ESM) and some independent cancer predictors may affect this outcome. The present study aimed to compare the rate of EC at hyst...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400146/ https://www.ncbi.nlm.nih.gov/pubmed/32668563 http://dx.doi.org/10.3390/diagnostics10070474 |
_version_ | 1783566297482657792 |
---|---|
author | Giannella, Luca Delli Carpini, Giovanni Sopracordevole, Francesco Papiccio, Maria Serri, Matteo Giorda, Giorgio Tsiroglou, Dimitrios Del Fabro, Anna Ciavattini, Andrea |
author_facet | Giannella, Luca Delli Carpini, Giovanni Sopracordevole, Francesco Papiccio, Maria Serri, Matteo Giorda, Giorgio Tsiroglou, Dimitrios Del Fabro, Anna Ciavattini, Andrea |
author_sort | Giannella, Luca |
collection | PubMed |
description | Background: Up to 40% of women with atypical endometrial hyperplasia (AEH) can reveal endometrial cancer (EC) at hysterectomy. The pre-operative endometrial sampling method (ESM) and some independent cancer predictors may affect this outcome. The present study aimed to compare the rate of EC at hysterectomy in women with AEH undergoing dilation and curettage (D&C), hysteroscopically-guided biopsy (HSC-bio), or hysteroscopic endometrial resection (HSC-res). The secondary outcome was to compare the reliability of ESMs in women showing independent variables associated with EC. Methods: Two-hundred-and-eight consecutive women with AEH and undergoing hysterectomy between January 2000 and December 2017 were analyzed retrospectively. Based on pre- and post-test probability analysis for EC, three ESMs were compared: D&C, HSC-bio, and HSC-res. Univariate and multivariate analyses were performed to assess risk factors predicting cancer on final histology. Finally, the patient’s characteristics were compared between the three ESM groups. Results: D&C and HSC-bio included 75 women in each group, while HSC-res included 58 women. Forty-nine women (23.6%) revealed cancer at hysterectomy (pre-test probability). Post-test probability analysis showed that HSC-res had the lowest percentage of EC underestimation: HSC-res = 11.6%; HSC-bio = 19.5%; D&C = 35.3%. Patient characteristics showed no significant differences between the three ESMs. Multivariate analysis showed that body mass index ≥40 (Odds Ratio (OR) = 19.75; Confidence Intervals (CI) 2.193–177.829), and age (criterion > 60 years) (OR = 1.055, CI 1.002–1.111) associated significantly with EC. In women with one or both risk factors, post-test probability analysis showed that HSC-res was the only method with a lower EC rate at hysterectomy compared to a pre-test probability of 44.2%: HSC-res = 19.96%; HSC-bio = 53.81%; D&C = 63.12%. Conclusions: HSC-res provided the lowest rate of EC underestimation in AEH, also in women showing EC predictors. These data may be considered for better diagnostic and therapeutic planning of AEH. |
format | Online Article Text |
id | pubmed-7400146 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74001462020-08-23 Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors Giannella, Luca Delli Carpini, Giovanni Sopracordevole, Francesco Papiccio, Maria Serri, Matteo Giorda, Giorgio Tsiroglou, Dimitrios Del Fabro, Anna Ciavattini, Andrea Diagnostics (Basel) Article Background: Up to 40% of women with atypical endometrial hyperplasia (AEH) can reveal endometrial cancer (EC) at hysterectomy. The pre-operative endometrial sampling method (ESM) and some independent cancer predictors may affect this outcome. The present study aimed to compare the rate of EC at hysterectomy in women with AEH undergoing dilation and curettage (D&C), hysteroscopically-guided biopsy (HSC-bio), or hysteroscopic endometrial resection (HSC-res). The secondary outcome was to compare the reliability of ESMs in women showing independent variables associated with EC. Methods: Two-hundred-and-eight consecutive women with AEH and undergoing hysterectomy between January 2000 and December 2017 were analyzed retrospectively. Based on pre- and post-test probability analysis for EC, three ESMs were compared: D&C, HSC-bio, and HSC-res. Univariate and multivariate analyses were performed to assess risk factors predicting cancer on final histology. Finally, the patient’s characteristics were compared between the three ESM groups. Results: D&C and HSC-bio included 75 women in each group, while HSC-res included 58 women. Forty-nine women (23.6%) revealed cancer at hysterectomy (pre-test probability). Post-test probability analysis showed that HSC-res had the lowest percentage of EC underestimation: HSC-res = 11.6%; HSC-bio = 19.5%; D&C = 35.3%. Patient characteristics showed no significant differences between the three ESMs. Multivariate analysis showed that body mass index ≥40 (Odds Ratio (OR) = 19.75; Confidence Intervals (CI) 2.193–177.829), and age (criterion > 60 years) (OR = 1.055, CI 1.002–1.111) associated significantly with EC. In women with one or both risk factors, post-test probability analysis showed that HSC-res was the only method with a lower EC rate at hysterectomy compared to a pre-test probability of 44.2%: HSC-res = 19.96%; HSC-bio = 53.81%; D&C = 63.12%. Conclusions: HSC-res provided the lowest rate of EC underestimation in AEH, also in women showing EC predictors. These data may be considered for better diagnostic and therapeutic planning of AEH. MDPI 2020-07-13 /pmc/articles/PMC7400146/ /pubmed/32668563 http://dx.doi.org/10.3390/diagnostics10070474 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Giannella, Luca Delli Carpini, Giovanni Sopracordevole, Francesco Papiccio, Maria Serri, Matteo Giorda, Giorgio Tsiroglou, Dimitrios Del Fabro, Anna Ciavattini, Andrea Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors |
title | Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors |
title_full | Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors |
title_fullStr | Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors |
title_full_unstemmed | Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors |
title_short | Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors |
title_sort | atypical endometrial hyperplasia and unexpected cancers at final histology: a study on endometrial sampling methods and risk factors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400146/ https://www.ncbi.nlm.nih.gov/pubmed/32668563 http://dx.doi.org/10.3390/diagnostics10070474 |
work_keys_str_mv | AT giannellaluca atypicalendometrialhyperplasiaandunexpectedcancersatfinalhistologyastudyonendometrialsamplingmethodsandriskfactors AT dellicarpinigiovanni atypicalendometrialhyperplasiaandunexpectedcancersatfinalhistologyastudyonendometrialsamplingmethodsandriskfactors AT sopracordevolefrancesco atypicalendometrialhyperplasiaandunexpectedcancersatfinalhistologyastudyonendometrialsamplingmethodsandriskfactors AT papicciomaria atypicalendometrialhyperplasiaandunexpectedcancersatfinalhistologyastudyonendometrialsamplingmethodsandriskfactors AT serrimatteo atypicalendometrialhyperplasiaandunexpectedcancersatfinalhistologyastudyonendometrialsamplingmethodsandriskfactors AT giordagiorgio atypicalendometrialhyperplasiaandunexpectedcancersatfinalhistologyastudyonendometrialsamplingmethodsandriskfactors AT tsirogloudimitrios atypicalendometrialhyperplasiaandunexpectedcancersatfinalhistologyastudyonendometrialsamplingmethodsandriskfactors AT delfabroanna atypicalendometrialhyperplasiaandunexpectedcancersatfinalhistologyastudyonendometrialsamplingmethodsandriskfactors AT ciavattiniandrea atypicalendometrialhyperplasiaandunexpectedcancersatfinalhistologyastudyonendometrialsamplingmethodsandriskfactors |